2026 Tandem Meetings
Trials whose public commentary places their results at 2026 Tandem Meetings, Feb 4–7, 2026. A trial is listed only when at least two public sources, from two publishers, place its results or presentation at the meeting; each row says how many did.
No trial is placed at 2026 Tandem Meetings by two sources yet. Organised by American Society for Transplantation and Cellular Therapy (ASTCT) and CIBMTR; Erudio is not affiliated with it.
Focused$750Standard$1,250Deep$1,950Pricing
Reports: each is priced by its size, licensed permanently for your organization's internal use, with MCP access for your AI agent. Buy on the report's page. Team and enterprise access
What clinicians said about each trial in public, every statement linked to its source. Counts: verified statements, and how many of them come from speakers whose clinical role the NPI registry or their institution's staff page confirms.
No published report on a trial placed at 2026 Tandem Meetings yet.
Trial pages with the registry record and the public commentary we have indexed so far. The report is built on order from the trial page. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price.
No trial is placed at 2026 Tandem Meetings by two sources.